管理患有频繁呼吸道感染和相关喘息的儿童:一项初步随机研究,使用了一种新的多组分鼻喷雾剂
Maria Angela Tosca1, Attilio Varricchio2, Irene Schiavetti3
1Allergy Center, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
这项初步研究发现,含有乳酸,二糖酸盐,碳甲基-β-葡萄糖和维生素C和维生素D3 (萨夫洛维尔) 的鼻喷剂可减少学龄前儿童的呼吸道感染和喘息发作.
科学领域:
- 儿科 儿科 儿科
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 幼儿园儿童容易患上呼吸道感染 (RIs) 和相关的喘息.
- 2型免疫反应可能会增加对RI和喘息的易感性.
- 非药物干预措施被探索为RI的补充疗法.
研究的目的:
- 评估一种新型多组分鼻喷雾剂对学龄前儿童频繁的鼻炎和喘息的疗效和安全性.
- 评估鼻喷雾作为标准护理的附加疗法的影响.
主要方法:
- 一个随机对照试验涉及学龄前儿童频繁的RI和喘息.
- 参与者接受了多组分鼻喷雾剂 (萨夫洛维尔) 或标准治疗3个月.
- 测量结果包括RI和喘息发作频率,药物使用和临床严重程度.
主要成果:
- 使用多组分鼻喷雾的儿童与对照组相比,鼻喷雾发生的次数显著减少 (P=0.01).
- 额外的鼻喷剂治疗导致减少对β-2激动剂的使用,以缓解喘息 (P=0.029).
结论:
- 这项初步研究表明,多组分鼻喷雾是一种安全有效的补充疗法,可以减少学龄前儿童的鼻炎.
- 鼻喷雾剂可以减少呼吸道感染的发生率,并减少对儿童喘息的症状治疗的需要.
更多相关视频
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
相关概念视频
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management
First, in...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Inhaled Medications
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
COPD: Management Using Bronchodilators and Corticosteroids
